Five Questions With a16z’s Vijay Pande on AI and Making New Drugs
Xconomy
NOVEMBER 25, 2019
Those tools—artificial intelligence and machine learning, respectively—have been around for decades, but in recent years have become faster and cheaper, accelerating their use by those in the business of discovering and developing new drugs. Andreessen Horowitz, also.
Let's personalize your content